European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission

Francois-Xavier Mahon*, Markus Pfirrmann, Stéphanie Dulucq, Andreas Hochhaus, Panayiotis Panayiotidis, Antonio Almeida, Jiri Mayer, Henrik Hjorth-Hansen, Jeroen J W M Janssen, Satu Mustjoki, Joaquin Martinez-Lopez, Hanne Vestergaard, Hans Ehrencrona, Katerina Machová Poláková, Ulla Olsson-Strömberg, Gert Ossenkoppele, Marc G Berger, Gabriel Etienne, Jolanta Dengler, Tim H BrümmendorfAndreas Burchert, Delphine Réa, Philippe Rousselot, Franck E Nicolini, Wolf-Karsten Hofmann, Johan Richter, Susanne Saussele, EURO-SKI investigators

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

Fingerprint

Dive into the research topics of 'European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science